Results
|
|
2301.
|
|
|
|
2302.
|
|
|
|
2303.
|
Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer. [electronic resource] by
- Kijima, Toshiki
- Fujii, Yasuhisa
- Yokoyama, Minato
- Ishioka, Junichiro
- Matsuoka, Yoh
- Numao, Noboru
- Saito, Kazutaka
- Koga, Fumitaka
- Masuda, Hitoshi
- Kawakami, Satoru
- Kihara, Kazunori
Producer: 20121207
In:
BJU international vol. 110
Availability: No items available.
|
|
|
2304.
|
|
|
|
2305.
|
|
|
|
2306.
|
|
|
|
2307.
|
|
|
|
2308.
|
|
|
|
2309.
|
|
|
|
2310.
|
|
|
|
2311.
|
A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer. [electronic resource] by
- Chow, Helen
- Ghosh, Paramita M
- deVere White, Ralph
- Evans, Christopher P
- Dall'Era, Marc A
- Yap, Stanley A
- Li, Yueju
- Beckett, Laurel A
- Lara, Primo N
- Pan, Chong-Xian
Producer: 20170315
In:
Cancer vol. 122
Availability: No items available.
|
|
|
2312.
|
|
|
|
2313.
|
|
|
|
2314.
|
|
|
|
2315.
|
|
|
|
2316.
|
|
|
|
2317.
|
A randomised comparison of bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate cancer. First report from the Scandinavian Prostatic Cancer Group Study No. 6. [electronic resource] by
- Iversen, P
- Tammela, T L J
- Vaage, S
- Lukkarinen, O
- Lodding, P
- Bull-Njaa, T
- Viitanen, J
- Hoisaeter, P
- Lundmo, P
- Rasmussen, F
- Johansson, J-E
- Persson, B-E
- Carroll, K
Producer: 20030114
In:
European urology vol. 42
Availability: No items available.
|
|
|
2318.
|
|
|
|
2319.
|
|
|
|
2320.
|
|